24 results
8-K
EX-99.1
INVA
Innoviva Inc
18 May 10
Other Events
12:00am
Demographics
· Patient demographic details are given in Table 1. Twenty patients with COPD participated in the study with 19, 20, 19 and 8 receiving … placebo and 25, 50 and 100mcg VI, respectively.
Table 1. Demographic details
Age, years mean (range)
Sex, n (%)
Female
Male
FEV1/FVC ratio, mean
8-K
EX-99.2
INVA
Innoviva Inc
18 May 10
Other Events
12:00am
· Subject demographic details are given in Table 1. Thirty six healthy subjects (35 male: 1 female) participated in the study.
Table 1. Demographic details
8-K
EX-99.4
INVA
Innoviva Inc
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
of efficacy
AE
1 (<1)
Withdrew consent
1 (<1)
Protocol deviation
1 (<1)
Investigator discretion
1 (<1)
Lost to follow-up
1 (<1)
· Demographic … , indicating a similar severity of illness between groups (Table 2).
Table 2. Demographic and clinical characteristics
(ITT population).
FF dose
FP dose
SC TO-C
EX-99.2
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:54pm
once-daily dosing in an easy-to-use deviceHistorical resilience in a competitive, volatile environment supported by positive demographic trends Net … by demographic tailwinds, increasing class adoption, and share increase across geographies 15% economics to INVA3
Relevant experience Management Team Pavel
8-K
EX-99.1
INVA
Innoviva Inc
13 Dec 21
Corporate Presentation December 2021
4:39pm
by positive demographic trends Net global sales ($B) Implied royalties ($M) (fluticasone furoate 100 mcg and vilanterol 25 mcg inhalation powder) Indications … trials for COPD vs double combination drug classes 2 Strong growth driven by demographic tailwinds, increasing class adoption, and share increase
8-K
EX-99.1
b6ngeca liktn7tgh
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
o3jlc
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
EX-99.2
keq2zql
22 May 12
Other Events
12:00am
8-K
EX-99.16
ini8 l1gkqfqc
4 Sep 12
Other Events
12:00am
8-K
EX-99.12
n77fcnn9wfa1y5cn 7b
4 Sep 12
Other Events
12:00am
8-K
EX-99.15
fu7pu4yr glci
4 Sep 12
Other Events
12:00am
8-K
EX-99.2
avs2ckecbxkig9xvm
27 Oct 08
Other Events
12:00am
8-K
EX-99.1
g1xbu84
19 Mar 08
Regulation FD Disclosure
12:00am
8-K
EX-99.1
le0kee
24 Oct 12
An analysis of the dose response of umeclidinium (GSK573719) administered once or twice daily in patients with COPD
12:00am
8-K
EX-99
6uh5oflbr6stvsk5
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
8-K
EX-99.3
35bs9xv kht7
22 May 12
Other Events
12:00am
8-K
EX-99.3
z6309ugyrlpnctwtt2l
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.1
ujwwc54 lwi
20 Sep 10
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily efficacy in asthma when dosed in the evening
12:00am
8-K
EX-99.1
lzahcayn7e55fj
14 Sep 22
Regulation FD Disclosure
5:22pm
8-K
EX-99.1
ime fk9ie92zy
24 May 23
Corporate Presentation May 2023
5:18pm